Uncertainty Surrounding Overseas and Domestic Procurement of Crude Herbal Drugs
First written in FY2016. 27 of 30 entries say "Restated". Latest entry: FY2026.
2 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「しかしながら、予期せぬ現地の天候不順や災害、規制等により原料生薬の量的確保ができない状況が続いた場合又は価格が大幅に高騰した場合には、当社の業績及び財政状態に影響を及ぼす可能性があります。」
原料生薬の量的確保不能および価格高騰による影響可能性を継続して記載している。 - FY2026-H1RestatedAnnual report
「当中間会計期間において、当半期報告書に記載した事業の状況、経理の状況等に関する事項のうち、経営者が提出会社の財政状態、経営成績及びキャッシュ・フローの状況に重要な影響を及ぼす可能性があると認識している主要なリスクの発生又は前事業年度の有価証券報告書に記載した「事業等のリスク」についての重要な変更はありません。」
海外・国内の原料生薬調達の不確実性について、重要な変更はないとしている。 - FY2025-H1RestatedAnnual report
「During the interim accounting period under review, there were no new major risks that management recognizes could have a material impact on the financial condition, operating results or cash flows of the filing company, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないとしている。 - FY2024-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no new major risks that management recognizes could have a material impact on the financial condition, operating results or cash flows of the filing company, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないとしている。 - FY2023RestatedAnnual report
「しかしながら、予期せぬ現地の天候不順や災害、規制等により原料生薬の量的確保ができない状況が続いた場合又は価格が大幅に高騰した場合には、当社の業績及び財政状態に影響を及ぼす可能性があります。」
天候不順、災害、規制による量的確保不能に加え、原料価格高騰による影響可能性を継続して記載している。 - FY2023-Q3RestatedAnnual report
「当第３四半期累計期間において、当四半期報告書に記載した事業の状況、経理の状況等に関する事項のうち、経営者が提出会社の財政状態、経営成績及びキャッシュ・フローの状況に重要な影響を及ぼす可能性があると認識している主要なリスクの発生又は前事業年度の有価証券報告書に記載した「事業等のリスク」についての重要な変更はありません。」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no new major risks that management recognizes could have a material impact on the financial condition, operating results or cash flows of the filing company, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2023-Q1WorsenedAnnual report
「当第１四半期累計期間（2022年４月１日から2022年６月30日まで）におけるわが国経済は、新型コロナウイルス感染症対策等により、経済社会活動は正常化に向かいつつあるものの、原材料価格の上昇や供給面での制約に加え、金融資本市場の変動等の影響等から景気は依然として厳しい状況が続いており、先行き不透明な状況で推移いたしました。」
原材料価格の上昇および供給面での制約を、原料調達に関わる新たな負担要因として明示している。 - FY2022-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no new major risks that management recognizes could have a material impact on the financial condition, operating results or cash flows of the filing company, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2022-Q1RestatedAnnual report
「There were no new major risks during the three months ended 30 June, and no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2021RestatedAnnual report
「しかしながら、予期せぬ現地の天候不順や災害、規制等により原料生薬の量的確保ができない状況が続いた場合又は価格が大幅に高騰した場合には、当社の業績及び財政状態に影響を及ぼす可能性があります。」
天候不順、災害、規制による量的確保不能に加え、価格高騰による影響可能性を引き続き記載している。 - FY2021-Q3RestatedAnnual report
「During the first three quarters of the current fiscal year, there were no new occurrences of the major risks that management recognises could materially affect the filing company's financial position, operating results or cash flows among the matters relating to business conditions, financial conditions and other matters described in the quarterly report, and no material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no new major risks that management recognizes could have a material impact on the financial condition, operating results or cash flows of the filing company, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2021-Q1RestatedAnnual report
「There were no new major risks during the three months ended 30 June, and no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2020WorsenedAnnual report
「しかしながら、予期せぬ現地の天候不順や災害、規制等により原料生薬の量的確保ができない状況が続いた場合又は価格が大幅に高騰した場合には、当社の業績及び財政状態に影響を及ぼす可能性があります。」
従来の量的確保リスクに、原料価格の大幅な高騰を新たな影響要因として加えている。 - FY2020-Q2RestatedAnnual report
「During the cumulative second quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2020-Q1RestatedAnnual report
「During the cumulative first quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2019RestatedAnnual report
「However, if conditions preventing the quantitative procurement of crude drug ingredients continue because of unexpected local weather disruptions, natural disasters, regulations or other factors, production may be disrupted, potentially affecting our operating results and financial position.」
天候不順、災害、規制等による原料生薬の量的確保不能リスクを再掲している。 - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2019-Q1RestatedAnnual report
「During the cumulative first quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2018RestatedAnnual report
「However, if conditions preventing the quantitative procurement of crude drug ingredients continue because of unexpected local weather disruptions, natural disasters, regulations or other factors, production may be disrupted, potentially affecting our operating results and financial position.」
天候不順、災害、規制等による原料生薬の量的確保不能リスクを再掲している。 - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2018-Q1RestatedAnnual report
「During the cumulative first quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2017RestatedAnnual report
「However, if conditions preventing the quantitative procurement of crude drug ingredients continue because of unexpected local weather disruptions, natural disasters, regulations or other factors, production may be disrupted, potentially affecting our operating results and financial position.」
天候不順、災害、規制等による原料生薬の量的確保不能リスクを再掲している。 - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
海外・国内の原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2017-Q1RestatedAnnual report
「There have been no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
原料生薬調達の不確実性について、重要な変更はないと記載している。 - FY2016First statedAnnual report
「However, if conditions preventing the quantitative procurement of crude drug ingredients continue because of unexpected local weather disruptions, natural disasters, regulations or other factors, production may be disrupted, potentially affecting our operating results and financial position.」
The company identifies the risk that weather disruptions, natural disasters or regulations could prevent it from securing sufficient quantities of crude drug ingredients and affect production and performance.